Ornithine Aspartate and Vitamin-E Combination Has Beneficial Effects on Cardiovascular Risk Factors in an Animal Model of Nonalcoholic Fatty Liver Disease in Rats

Cardiovascular (CV) disease is the main cause of death in nonalcoholic fatty liver disease (NAFLD), a clinical condition without any approved pharmacological therapy. Thus, we investigated the effects of ornithine aspartate (LOLA) and/or Vitamin E (VitE) on CV parameters in a steatohepatitis experim...

Descripción completa

Detalles Bibliográficos
Autores principales: de Freitas, Laura Bainy Rodrigues, Longo, Larisse, Filippi-Chiela, Eduardo, de Souza, Valessa Emanoele Gabriel, Behrens, Luiza, Pereira, Matheus Henrique Mariano, Leonhard, Luiza Cecília, Zanettini, Giulianna, Pinzon, Carlos Eduardo, Luchese, Eduardo, Lima, Guilherme Jorge Semmelmann Pereira, Cerski, Carlos Thadeu, Uribe-Cruz, Carolina, Álvares-da-Silva, Mário Reis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775092/
https://www.ncbi.nlm.nih.gov/pubmed/36551202
http://dx.doi.org/10.3390/biom12121773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775092/
https://www.ncbi.nlm.nih.gov/pubmed/36551202
http://dx.doi.org/10.3390/biom12121773

Ejemplares similares